This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (September 2021) (Learn how and when to remove this message) |
Eleanor Barnes | |
---|---|
Alma mater | University of Oxford St Bartholomew's Hospital |
Scientific career | |
Institutions | John Radcliffe Hospital University of Oxford |
Thesis | T-cell and dendritic cell function and the effects of combination therapy in Hepatitis C virus infection (2004) |
Eleanor Barnes is a British physician at the John Radcliffe Hospital and a Professor of Hepatology and Experimental Medicine at the University of Oxford. She has studied hepatitis C and the development of the development of HCV vaccines. She is a Fellow of the Academy of Medical Sciences and serves as the lead for hepatology at the National Institute for Health Research (NIHR) Clinical Research Network.
Early life and education
Barnes has said that she was interested in science as a child. She decided to study medicine at university, and eventually trained at St Bartholomew's Hospital. She completed an intercalated bachelor's degree in anthropology and philosophy. After graduating, she worked as a medical resident at the Royal Free Hospital, where she decided to specialise in hepatology and gastroenterology. Determined to pursue a career in research, Barnes worked unpaid for three months, during which time she obtained data that she used to apply for a fellowship from the Medical Research Council. She was a doctoral researcher at the University of Oxford. Her doctoral research considered T cell and dendritic cell function.
Research and career
Barners' research considers T cell immunology. She is focused on the translation of laboratory findings to clinical environments. Barnes worked as a Medical Research Council Senior Fellow at the University of Oxford, and eventually was appointed lead of herpetology in the Thames Valley. She studied why 80% of patients with hepatitis C get chronic infection. Barnes identified that the nature of the T cell response determines which pathway a patient goes down. This observation led Barnes to develop an T-cell vaccine to prevent hepatitis C infection. The vaccine is based on adenoviral vectors, which host the non-structural proteins of hepatitis C from a genotype 1B strain. There are seven major hepatitis C strains, which presents considerable challenges for the development of vaccines. Barnes was elected Fellow of the Academy of Medical Sciences in 2018.
During the COVID-19 pandemic, Barnes studied the design, effectiveness and implementation of the COVID-19 vaccine. She showed that patients who suffered from COVID-19 were likely to be impacted by liver problems.
Selected publications
- Jane P Messina; Isla Humphreys; Abraham Flaxman; Anthony Brown; Graham S Cooke; Oliver G Pybus; Eleanor Barnes (28 July 2014). "Global distribution and prevalence of hepatitis C virus genotypes". Hepatology. 61 (1): 77–87. doi:10.1002/HEP.27259. ISSN 0270-9139. PMC 4303918. PMID 25069599. Wikidata Q34431175.
- Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; et al. (8 December 2020). "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK". The Lancet. 397 (10269): 99–111. doi:10.1016/S0140-6736(20)32661-1. ISSN 0140-6736. PMC 7723445. PMID 33306989. Wikidata Q104286457.
- Pedro M Folegatti; Katie J Ewer; Parvinder K Aley; et al. (20 July 2020). "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial". The Lancet. doi:10.1016/S0140-6736(20)31604-4. ISSN 0140-6736. PMC 7445431. PMID 32702298. Wikidata Q97678476.
Personal life
Barnes is married with two children.
References
- "Ellie (Eleanor) Barnes". Nuffield Department of Medicine, University of Oxford. Archived from the original on 22 September 2020. Retrieved 22 December 2021.
- ^ "Eleanor Barnes — Diversity Projects". parking.haiku.fry-it.com. Retrieved 18 September 2021.
- "Eleanor Barnes — Diversity Projects". parking.haiku.fry-it.com. Retrieved 1 March 2022.
- Barnes, Eleanor (2004). T-cell and dendritic cell function and the effects of combination therapy in Hepatitis C virus infection (Thesis). OCLC 1169825441.
- ^ "Ellie Barnes: Women in Science - Internal Speaker — Working for NDM". www.ndm.ox.ac.uk. Retrieved 18 September 2021.
- "PITCH Study". www.pitch-study.org. Retrieved 18 September 2021.
- "Professor Eleanor Barnes | The Academy of Medical Sciences". acmedsci.ac.uk. Retrieved 18 September 2021.
- "UK scientists back Covid boosters as study finds post-jab falls in antibodies". the Guardian. 22 July 2021. Retrieved 18 September 2021.
- "Liver problems common among COVID-19 patients, study finds". NIHR Oxford Biomedical Research Centre. 23 July 2021. Retrieved 18 September 2021.
- Fellows of the Academy of Medical Sciences (United Kingdom)
- British women scientists
- British women academics
- Academics of the University of Oxford
- 20th-century British medical doctors
- 20th-century British women medical doctors
- 21st-century British medical doctors
- NIHR Senior Investigators
- Hepatitis researchers
- Living people
- Alumni of the University of Oxford